Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNotes PayablesPayablesPreferred SharesProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Us Nuclear (UCLE) Liabilities and Shareholders Equity (2017 - 2025)

Us Nuclear's Liabilities and Shareholders Equity history spans 9 years, with the latest figure at $2.5 million for Q3 2025.

  • For Q3 2025, Liabilities and Shareholders Equity rose 196.73% year-over-year to $2.5 million; the TTM value through Sep 2025 reached $10.2 million, up 18.59%, while the annual FY2024 figure was $2.6 million, 7.35% down from the prior year.
  • Liabilities and Shareholders Equity for Q3 2025 was $2.5 million at Us Nuclear, up from $2.5 million in the prior quarter.
  • Across five years, Liabilities and Shareholders Equity topped out at $3.2 million in Q1 2023 and bottomed at $855231.0 in Q3 2024.
  • The 5-year median for Liabilities and Shareholders Equity is $2.6 million (2024), against an average of $2.6 million.
  • The largest annual shift saw Liabilities and Shareholders Equity plummeted 72.44% in 2024 before it soared 196.73% in 2025.
  • A 5-year view of Liabilities and Shareholders Equity shows it stood at $2.9 million in 2021, then rose by 9.03% to $3.1 million in 2022, then decreased by 8.1% to $2.9 million in 2023, then dropped by 7.35% to $2.6 million in 2024, then dropped by 4.12% to $2.5 million in 2025.
  • Per Business Quant, the three most recent readings for UCLE's Liabilities and Shareholders Equity are $2.5 million (Q3 2025), $2.5 million (Q2 2025), and $2.5 million (Q1 2025).